| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer | SVP &Chief Medical Officer
1 company
Paolini John F. is a Chief Medical Officer at Kiniksa Pharmaceuticals International, plc. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $8.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Medical Officer | Sale+OE | 28,357 | $15.18 | $430,459.26 | -43.8% | -6.6% | +8.3% | |
| Feb 20, 2020 | KNSA Kiniksa Pharmaceuticals International, Plc | SVP &Chief Medical Officer | Sale+OE | 32,280 | $18.48 | $596,487.08 | -36.9% | - | - | |
| Feb 14, 2020 | KNSA Kiniksa Pharmaceuticals International, Plc | SVP &Chief Medical Officer | Sale+OE | 11,316 | $18.29 | $207,011.20 | -23.9% | - | - |